EGFR-targeting antitumor therapy: Neuregulins or antibodies?

  1. de Lavera, I.
  2. Merkling, P.J.
  3. Oliva, J.M.
  4. Sayagués, M.J.
  5. Cotán, D.
  6. Sánchez-Alcázar, J.A.
  7. Infante, J.J.
  8. Zaderenko, A.P.
Journal:
European Journal of Pharmaceutical Sciences

ISSN: 1879-0720,  0928-0987

Year of publication: 2021

Volume: 158

Type: Article

DOI: 10.1016/J.EJPS.2020.105678 GOOGLE SCHOLAR

Sustainable development goals

info

SDG classification obtained using Aurora SDG artificial intelligence model.

Data source: Scopus